Literature DB >> 28822348

Risk factors for potential drug-drug interactions in intensive care unit patients.

Slobodan M Janković1, Ana V Pejčić2, Miloš N Milosavljević1, Valentina D Opančina1, Nikola V Pešić1, Tamara T Nedeljković1, Goran M Babić3.   

Abstract

PURPOSE: To determine risk factors for each severity-based category of potential drug-drug interactions (DDIs) encountered at intensive care unit (ICU) patients.
METHODS: This was a retrospective cohort analysis of patients treated at the ICU of the Clinical Center Kragujevac, a public tertiary care hospital in Kragujevac, Serbia. Three interaction checkers were used to reveal drug-drug interactions: Medscape, Epocrates and Micromedex.
RESULTS: The study included 201 patients, 66.19±16.11 years of age. Average number of DDIs per patient ranged from 10.49±8.80 (Micromedex) to 29.43±21.51 (Medscape). Antiarrhythmic or anticonvulsant drug prescription, Charlson Comorbidity Index, male sex, length of hospitalization, number of drugs or therapeutic groups prescribed and surgery increased the risk of DDIs in ICU patients, while presence of delirium or dementia and transfer from emergency department to ICU protected against.
CONCLUSIONS: The rate of the DDIs in ICU patients at a tertiary care hospital is high, and adversely influenced by number of drugs or drug groups prescribed per patient, antiarrhythmic or anticonvulsant drug prescription, comorbidities, length of hospitalization and surgery. On the other hand, presence of cognitive deficit and transfer from emergency department to ICU protect ICU patients from the DDIs.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Drug-drug interactions; Intensive care unit; Risk factors

Mesh:

Year:  2017        PMID: 28822348     DOI: 10.1016/j.jcrc.2017.08.021

Source DB:  PubMed          Journal:  J Crit Care        ISSN: 0883-9441            Impact factor:   3.425


  16 in total

1.  Is prophylaxis worse than treatment in the ICU?

Authors:  Fernando G Zampieri; Matt P G Morgan; Morten Hylander Møller
Journal:  Intensive Care Med       Date:  2019-07-29       Impact factor: 17.440

Review 2.  Evaluation of Potential Drug-Drug Interactions in Adults in the Intensive Care Unit: A Systematic Review and Meta-Analysis.

Authors:  Mary Grace Fitzmaurice; Adrian Wong; Hannah Akerberg; Simona Avramovska; Pamela L Smithburger; Mitchell S Buckley; Sandra L Kane-Gill
Journal:  Drug Saf       Date:  2019-09       Impact factor: 5.606

3.  Drug-drug interactions in patients with acute coronary syndrome across phases of treatment.

Authors:  Ana V Pejčić; Slobodan M Janković; Goran Davidović
Journal:  Intern Emerg Med       Date:  2018-11-27       Impact factor: 3.397

Review 4.  Prevalence of drug interactions in hospitalised elderly patients: a systematic review.

Authors:  Luciana Mello de Oliveira; Juliana do Amaral Carneiro Diel; Alessandra Nunes; Tatiane da Silva Dal Pizzol
Journal:  Eur J Hosp Pharm       Date:  2020-02-10

5.  Potential drug-drug interactions and associated factors among hospitalized cardiac patients at Jimma University Medical Center, Southwest Ethiopia.

Authors:  Netsanet Diksis; Tsegaye Melaku; Desta Assefa; Andualem Tesfaye
Journal:  SAGE Open Med       Date:  2019-06-11

6.  The Prevalence of the Potential Drug-Drug Interactions Involving Anticancer Drugs in China: A Retrospective Study.

Authors:  Weilan Wang; Bingkun Xiao; Ziqi Liu; Dongxiao Wang; Man Zhu
Journal:  Iran J Public Health       Date:  2019-03       Impact factor: 1.429

7.  The effect of different intensivist staffing patterns on the rate of potential drug-drug interactions in adult trauma intensive care units.

Authors:  Mansoor Masjedi; Mahtabalsadat Mirjalili; Ehsan Mirzaei; Hadis Mirzaee; Afsaneh Vazin
Journal:  Ther Adv Drug Saf       Date:  2020-12-28

8.  Clinical significance of potential drug-drug interactions in a pediatric intensive care unit: A single-center retrospective study.

Authors:  Yu Hyeon Choi; In Hwa Lee; Mihee Yang; Yoon Sook Cho; Yun Hee Jo; Hye Jung Bae; You Sun Kim; June Dong Park
Journal:  PLoS One       Date:  2021-02-08       Impact factor: 3.240

9.  Prevalence of potential drug-drug interactions in outpatients of a general hospital in China: a retrospective investigation.

Authors:  Weifang Ren; Yujuan Liu; Jun Zhang; Zhonghong Fang; Huan Fang; Yuan Gong; Xiaoqun Lv
Journal:  Int J Clin Pharm       Date:  2020-06-03

10.  Prevalence of potential drug-drug interactions and associated factors among outpatients and inpatients in Ethiopian hospitals: a systematic review and meta-analysis of observational studies.

Authors:  Wondim Ayenew; Getahun Asmamaw; Arebu Issa
Journal:  BMC Pharmacol Toxicol       Date:  2020-08-24       Impact factor: 2.483

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.